[Patent foramen ovale, stroke, and echocardiography: diagnostic methodology and appropriateness of indications]

Area of Science:

• Cardiology
• Neurology
• Embryology

Background:

• Patent foramen ovale (PFO) is a common congenital heart anomaly with significant clinical implications.
• PFO is implicated in stroke, decompression sickness, and migraine headaches through mechanisms like paradoxical embolization and in situ thrombosis.

Purpose of the Study:

• To discuss the diagnostic approaches for identifying cardiac right-to-left shunts.
• To evaluate the relative value of different diagnostic tests and their impact on patient management.
• To review the current evidence for therapeutic interventions in patients with PFO.

Main Methods:

• Echocardiography and transcranial Doppler ultrasound with contrast agents and Valsalva maneuver for shunt identification.
• Discussion of diagnostic test parameters like timing, diagnostic windows, and microbubble detection thresholds.
• Review of existing literature on anticoagulation and device/surgical closure efficacy.

Main Results:

• Diagnostic tests can identify shunts, but their impact on patient management and outcomes requires careful consideration.
• Evidence is insufficient to determine the superiority of warfarin or aspirin for recurrent stroke prevention in cryptogenic stroke patients with atrial septal abnormalities.
• Minor bleeding is more frequent with warfarin compared to aspirin.

Conclusions:

• The appropriate use of diagnostic imaging for PFO requires understanding both imaging capabilities and therapeutic value.
• There is insufficient evidence to support the efficacy of surgical or endovascular closure for PFO.
• Further research is needed to establish optimal management strategies for patients with PFO and associated conditions.